Diabetes drug boosts survival in patients with COVID-19 pneumonia
Mortality was halved in hospitalised diabetes patients given sitagliptin in addition to insulin.
Published
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via
Are you a GP or Specialist Doctor, practising in UK, looking for:
- easy-to-digest, relevant updates and educational content
- a safe-space to share and collaborate with peers?
OnMedica is for you, sign up FOR FREE now!
No comments yet.